相关实验视频

Updated: Jun 4, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

瘤透性淋巴细胞 (TIL) 作为预后因素和治疗侵入性皮肤黑色素瘤的进展

Gabriel Alves Freiria de Oliveira¹, Daniel Arcuschin de Oliveira¹, Melissa Yoshimi Sakamoto Maeda Nisimoto¹

¹Melanoma and Skin Tumors Sector, Plastic Surgery Discipline, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), Rua Botucatu, 740, São Paulo 04023-062, SP, Brazil.

International journal of molecular sciences

|December 17, 2024

概括

瘤透淋巴细胞 (TILs) 疗法对其他治疗方法耐药的晚期黑色素瘤患者有前途. 这篇评论探讨了TIL疗法.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
皮肤病学皮肤病学

背景情况:

侵袭性皮肤黑色素瘤占皮肤瘤的5%,但占皮肤癌死亡人数的70%.
治疗耐药性仍然是一个重大挑战,尽管有免疫疗法和向药物等进展,但超过一半的患者屈服于治疗.
结合治疗方法和探索新疗法对于改善黑色素瘤存活率至关重要.

研究的目的:

为了引入瘤透性淋巴细胞 (TILs) 治疗.
审查最近的结果和TIL治疗在黑色素瘤管理中的预后影响.

主要方法:

对最近有关TIL治疗黑色素瘤的研究的文献综述.
对与TIL治疗相关的临床结果和预后因素的分析.

主要成果:

TIL疗法是对晚期黑色素瘤患者的有前途的选择,这些患者对标准治疗不耐药.
最近的结果表明,在精选的黑色素瘤患者群体中,预后可能会得到改善.
进一步的研究正在进行中,以优化TIL治疗方案和患者选择.

结论:

TIL疗法在治疗耐药黑色素瘤的管理方面取得了重大进展.
这种方法为改善患者存活率和临床结果提供了新的途径.
对TIL治疗的持续研究对于其更广泛的临床应用至关重要.

关键词:

这是皮肤黑色素瘤.黑色素瘤是一种黑色素瘤.发生转移的黑色素瘤.瘤透性淋巴细胞 (TILs) 是一种

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...